← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Function Therapeutics, Inc.
Milwaukee, WI
$1,991,724
Total funding
5
Grants
Funding over time
peak $788.7K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,717,014 · 4
NSF$274,710 · 1
By mechanism
R43$1,717,014 · 4
—$274,710 · 1
Investigators at Function Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain$499,863
R43 · FY2025 · NS
Small Molecule PAR1 Ligands for the Treatment of MASH$463,714
R43 · FY2024 · DK
Inhibitors of Thromboinflammation for Acute Kidney Injury$325,000
R43 · FY2024 · DK
Allosteric Modulation of PAR1 for the Treatment of Sickle Cell Disease$299,790
R43 · FY2023 · HL
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)$274,710
· FY2023 · TIP
Inhibitors of Thromboinflammation for Acute Kidney Injury$88,907
R43 · FY2025 · DK
Small Molecule PAR1 Ligands for the Treatment of MASH$39,740
R43 · FY2025 · DK